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SUMMARY 
 
  
 
Objectives: To determine the frequency and spectrum of oral and maxillofacial lesions 
biopsied in a hospital population in the northern region of Portugal.  
 
Methods: We conducted descriptive analysis of pathology reports from biopsies of oral and 
maxillofacial lesions performed between 1990 and 2006, in Oporto Hospital 
Center. Information on gender, age, location and the histopathological diagnosis were 
analysed. 
 
Results: The cases revealed that 1520 (47.7%) of the patients were male and 1666 (52.3%) 
patients were female. They had a mean age of 47.8 years (S.D.±18.6). The site most 
frequently biopsied was the labial mucosa (17.5%). A non-neoplastic diagnosis was 
established in 2162 (63.3%) cases, oral potentially malignant disorders in 163 (5.1%) cases, 
and neoplasms in 886 (27.6%) cases (403 benign and 483 malignant). The most reported 
diagnosis was fibroepithelial polyp (n=186;15.9%), followed by squamous cell carcinoma 
(SCC) (n=158;13.6%). SCC was the most frequent lesion found in males (n=279;18.4%) 
whilst fibroepithelial polyp was the most common diagnosis in females (n=268;16.1%). The 
most common lesion in patients aged 0 to 17 years-old was a follicular cyst (n=25;12.8%), 
whereas in patients aged 18 to 64 years it was a fibroepithelial polyp (n=299;13%). SCC was 
the most frequent lesion found in patients aged 65 or over (n=160;24.6%). 
 
Conclusion:  This large sample provides useful information about the incidence and 
distribution of oral biopsies over a period of 16 years allowing valuable comparison with 
other countries. Non-neoplastic lesions were the most commonly reported, with 
fibroepithelial polyp being most frequent. SCC was the second more frequent diagnosis. 
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INTRODUCTION 
  
The oral cavity can develop a wide range of lesions, with diverse origins and nature, 
including either benign or malignant lesions. Carrying out a biopsy is one of most important 
investigations in oral medicine. A biopsy not only shows the morphological characterisation 
of the tissue but also is the gold standard for obtaining a definitive diagnosis for many 
lesions, especially concerning malignant diseases1. Oral health professionals, including 
general dentists, are very familiar with dental and periodontal lesions. However, the diagnosis 
of some lesions and diseases of the oral soft tissues can be more challenging2. In view of this, 
literature on the frequency and prevalence of oral and maxillofacial lesions, not only increase 
awareness of disease patterns within populations, but highlight lesions that oral health 
professionals are most likely to face in their daily practice. 
 
Worldwide there have been few histological-based studies of oral and maxillofacial lesions 
which include both a comprehensive spectrum of oral lesions and patients of all ages3-7. Most 
of the published reports are designed to analyse only a specific lesion or disease, limited to a 
certain age group, or based on screenings or clinical surveys, without histological diagnostic 
confirmation8-18. 
 
The aim of this study was to determine the spectrum and the frequency of biopsied oral and 
maxillofacial lesions, in a North Portugal hospital population, comprising all ages and 
genders, and then to compare the results with other studies reported worldwide. 
  
 
MATERIAL AND METHODS 
  
We performed a retrospective, 16 year (1990-2006) descriptive analysis of oral and 
maxillofacial biopsies, at the Pathology Department of the Hospital de Santo António (HSA) 
Oporto Hospitalar Center in Portugal. Patients from the Oporto community were referred by 
their General Practitioner (GP) to this central based city hospital. The study was reviewed 
and approved by the institutional review board of the Hospital de Santo António (HSA) 
Oporto Hospitalar Center (Investigation, Formation and Teaching Department – DEFI; 
024/CES/03). The study was performed in full accordance with the World Medical 
Association Declaration of Helsinki. Data regarding histopathological diagnosis and 
respective clinical information were retrieved from patient hospital records and inserted into a 
Microsoft® Excel database. The data was anonymised prior to analysis. This included 
information on gender, age, site of the lesion, clinical diagnosis and the histopathological 
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diagnosis. Exclusion criteria were: biopsies showing normal tissue, repeated biopsies of 
already diagnosed lesions (e.g., the excisional removal of a lesion that was previously 
diagnosed with an incisional biopsy), and cases with unclear or missing data, or with an 
inconclusive diagnosis.  
 
The lesions were classified using a system recommended by the ICD-DA (International 
Classification of Diseases, Dentistry and Stomatology), and by the WHO classification of 
tumours (2005).  For analysis purposes, we decided to divide the diagnoses into 3 groups: 
non-neoplastic lesions, oral potentially malignant disorders (OPMD), and neoplastic lesions. 
These were further subdivided into 9 major subcategories: inflammatory lesions, infective 
lesions, cystic lesions, reactive lesions, potentially malignant disorders, autoimmune or 
metabolic diseases, hamartomatous lesions or congenital alterations, benign neoplasms and 
malignant neoplasms. Patients aged between 0 and 17 years old were considered young 
patients, with ages 18 to 64 classified as adult patients and patients 65 and over classified as 
elderly patients 19,20. 
 
Statistical analysis was carried out using IBM SPSS Statistics version 22.0 software (IBM 
Corporation, NY, US). The results were presented in absolute and relative frequency. 
Possible associations between pathological groups (non-neoplastic, OPMD and neoplastic 
groups) and categorical or continuous variables were evaluated by chi-square test or ANOVA 
test, respectively. A P-value of less than 0.05 was considered significant.  
 
 
 RESULTS 
  
From the original data set of 3737 cases, we excluded 136 cases as they revealed a 
histopathological diagnosis of normal tissue (without cellular or tissue alterations). A further 
389 cases were excluded for the following reasons; they were repeated biopsies for the same 
lesion, had missing data or had an unclear diagnosis. Therefore a final sample of 3212 oral 
biopsies were included. 1666 (52.3%) of these were from females and 1520 (47.7%) were 
from male patients (female: male ratio of 1.09). Within the sample, the patient’s age ranged 
from 3 to 100 years old, with a mean age of 47.8 years (S.D. ± 18.6) and the 6th decade being 
the most common (n=628; 20%). There were 196 (6.2%) cases in the young age group, 2300 
(73.1%) in adults and 651 (20.7%) in the elderly group. 
 
The most frequently affected oral site was the labial mucosa (n=561), followed by the buccal 
mucosa (n=550), tongue (n=519), gingiva (n=349), major salivary glands (n=300), palate 
(n=182), floor of the mouth (n=75), maxilla (n=357), mandible (n=287), and mouth NOS (not 
otherwise specified) (n=32). 
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When classified within pathological diagnostic groups, 2162 (63.3%) lesions corresponded to 
non-neoplastic diagnoses, 163 (5.1%) were OPMD, and 886 (27.6%) were neoplasms (Table 
1). The non-neoplastic biopsies were more likely to be from females than males, this was in 
contrast to potentially malignant disorders and neoplasms (P < 0.001) which were more 
commonly from male patients. The mean age of patients with non-neoplastic lesions was 
lower than those observed in patients with neoplasms or OPMD (P < 0.001). The buccal 
mucosa was the most affected site in non-neoplastic lesions and OPMD, while the tongue 
was the most affected site for neoplasms (P < 0.001). 
 
Non-neoplastic group 
 
The most common subcategory within non-neoplastic diagnoses was reactive lesions 
(n=679), followed by cystic lesions (n=647), inflammatory lesions (n=636), autoimmune or 
metabolic conditions (n=89), hamartomatous or congenital lesions (n=67), and infective 
lesions (n=45). The most prevalent reactive lesion was the fibroepithelial polyp (n=385). This 
was more commonly observed in females (n=268), patients affected had a mean age of 
48.9±16 years, and the buccal mucosa was most frequently affected (47%).  With regards to 
cysts and odontogenic tumours, the inflammatory odontogenic cyst was the most frequent 
lesion (n=264). The mean age of patients affected was 38.4±15.9, with males being more 
commonly affected (n=152), and it presenting mainly in the maxilla (69.7%). Other non-
neoplastic lesions and their distribution by gender, age and site are presented in Table 2 and 
Tables S1-S6. 
  
Oral Potentially Malignant Disorders 
 
Leukoplakia was the most common potentially malignant oral disorder (n=76) with a mean 
age of 57.53±15.66, and predominantly being found in males (n=48). The most affected 
location was the buccal mucosa (36.8%). Other potentially malignant oral disorders and their 
distribution by gender, mean age, and predominant location, are presented in Table 3. 
 
Neoplasms 
 
From the 886 neoplasms, 403 were benign and 483 were malignant (Table S7-8). The benign 
pleomorphic adenoma was the most frequent benign neoplasm, affecting mainly the major 
salivary glands (MSG) (75%) and especially the parotid gland (n=69; 83.1% of MSG), with 
more cases noted in females (n=69) with a mean age of 43.38±17.7 years old. If we exclude 
the major salivary glands the most frequent benign neoplasm was the epithelial cell papilloma 
(n=96; 34% of all oral cavity locations). The most common malignant neoplasm was 
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squamous cell carcinoma (n=373). This tumour was more common in males (n=279), the 
mean age of patients was 61.55±13.5 and it affected predominantly the tongue (30.8%).  
Regarding salivary gland malignancies, mucoepidermoid carcinoma (n=13) was the most 
common salivary gland malignancy, it mostly affected major salivary glands (38.5%) 
especially the parotid gland (n=5; 100% of MSG). This was followed by adenoid cystic 
carcinoma (n=10) located most often in the floor of the mouth (30%) and MSG (30%) 
especially in the submandibular gland (n=2; 66.6%). Table 4 shows the neoplastic lesions 
distributed by gender, mean age, and the predominant location. 
  
The Top 10 distributed by gender and age 
  
We investigated the ten most common diagnoses of the entire sample population (Figure 1). 
Fibroepithelial polyp (n=385) was the most common lesion, followed by squamous cell 
carcinoma (n=373). By analysing the distribution of the lesions according to gender, we 
observed that the fibroepithelial polyp (n=268) was the most frequent lesion found in 
females, whereas the most common lesion in males was SCC (n=279) (Figure 2). When we 
analysed the most common diagnoses divided by age group, follicular cyst (n=25) was the 
predominant lesion in the young age group (0 to 17 year-old), fibroepithelial polyp was the 
most common in the adult group (18 to 64 years) (n=299), and SCC (n=160) was the most 
prevalent in the elderly group (+ 65 years) (Figure 3). 
  
 
DISCUSSION 
  
Information on the frequency of oral and maxillofacial lesions is an important aspect of oral 
health practice and provides epidemiological information on the distribution of the lesions 
within the populations. From this descriptive retrospective analysis (1990-2006), 3212 oral 
biopsies were included representing a 16 year study period. This compares with Tay 3 who 
reviewed oral biopsies from 1993 to 1997, reviewing a total of 2057 reports, of which 1986 
separate diagnoses were recorded. Dimba et al. 7 reported a 4-year study of oral biopsies in a 
pathology laboratory at the University of Nairobi Dental Hospital, in Kenya, which included 
548 samples. While, Jones and Franklin 14 studied 44,000 oral and maxillofacial pathological 
specimens, from adults 17 years and over, submitted for diagnosis to a laboratory over a 30-
year period (1973-2002).  
 
The data obtained in our sample showed a slightly increased number of biopsies in females 
compared with males, consistent with findings reported by others 4,15,16. This could reflect a 
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greater female population in the north of Portugal (according to the Census of 2011). By 
contrast, analysing only the OPMD and neoplasms groups, we observed that these lesions 
affected males more frequently, as expected and confirmed by other data 5,6. 
 
All decades of life considered in the study were affected but there was a peak in the 
6th decade of life. This pattern was not true for all groups of lesions, as oral potentially 
malignant disorders and neoplasms showed a higher mean age and were therefore more 
common in older patients, whereas non-neoplastic lesions were more common in younger 
patients. This is in accordance with reported studies 15,21-24. 
 
The reactive lesion group was the most common pathological group. Fibroepithelial polyp 
was particularly common, representing 12% of the entire sample.  It was seen most 
commonly in the 5th decade of life, mainly in females and  located most often in the 
buccal mucosa, which is in accordance with data published in the literature 3,14,16,17,25.   
Indeed, fibroepithelial polyp was the most frequent lesion of the whole study. This is not 
surprising as the oral cavity is a unique organ that is often subjected to multiple traumatic and 
pathological stimuli such as fractured teeth, maladapted prostheses, malocclusion and other 
dental problems. 
 
Inflammatory odontogenic cysts were the most common lesions in the cystic and odontogenic 
tumours group, representing 8.2% of the overall sample. A greater number of cases were seen 
in the maxilla. By contrast, the second more frequent cyst; the follicular cyst, was more 
prevalent in the mandible. When the analysis was focused to the young group only, the 
follicular cyst was the most prevalent, as observed by Ha et al. 18. Mucoceles were the second 
most prevalent lesions in this group, most commonly observed in the labial mucosa of males, 
as reported by others 14,26. 
 
The most common autoimmune lesion was Sjögren's syndrome (n=18) which demonstrated 
a higher prevalence in females, in accordance with the literature 25,27. The elevated number of 
cases located in the labial mucosa for this disease reflects the preferred site for minor salivary 
gland biopsies. 
 
Regarding oral potentially malignant disorders, leukoplakia (n = 76) was the most prevalent, 
constituting 2.4% of the total sample, which is in line with several reports 4,11,14. The authors 
elected to include lichen planus as an OPMD as suggested by Warnalulasuryia et al 21. 
Although leukoplakia is a clinical term, given the importance of this lesion as a potentially 
malignant disorder, we chose to include this diagnosis within the OPMD group. This gave us 
a greater understanding of the frequency of oral potentially malignant disorders in this 
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population21. Following histological diagnosis, we reviewed the clinical history to confirm 
diagnosis of oral leukoplakia. Nevertheless, we admit, it is possible that some cases of 
leukoplakia which were absent of clinical information on the pathological report and the 
clinical history, could therefore be under the designation of epithelial hyperplasia or 
hyperkeratosis.  
 
The most common benign neoplasm was pleomorphic adenoma, followed by squamous cell 
papilloma. Indeed, these two benign neoplasms were also the most reported by Jones 
and Franklin14, although they reported squamous papilloma as the more prevalent lesion. 
Regarding salivary glands only, pleomorphic adenoma was the most common benign tumour, 
most commonly located in major salivary glands especially the parotid gland, followed by 
Warthin's tumour, that is consistent with the literature 27,28. 
 
Malignancy represented 15% of the overall sample, which is similar to that reported by Ali 
and Sundaram 29, but higher than that reported by Jones and Franklin 14 and Tay 3. The most 
common malignancy was squamous cell carcinoma, which was consistent with several 
reports 4,6,16,17,29. We feel this result clearly shows that biopsies are vital for the diagnosis of 
such a prevalent tumour. There was a predilection for the tongue as this was the most 
commonly affected site (32.9%) there was also a correlation with male gender and age of 70–
79. This is consistent with other reports 4,5,23,24,29. When we analysed the most frequent 
lesions distributed by gender and age, interestingly, SCC was the most prevalent lesion in 
males and in the elderly group. However, we must bear in mind that oral cancer, in both 
young adults and in females, is rising in several parts of the world including Portugal. In the 
last decade, an increasing trend for oral cancer in the Portuguese population has been 
reported, especially in females30.  
 
Regarding salivary gland malignant neoplasms, the mucoepidermoid carcinoma and adenoid 
cystic carcinoma were the most frequent malignant tumours, as observed by Correa et al. 15. 
This slight predominance of mucoepidermoid carcinoma over adenoid cystic carcinoma is in 
accordance with the reports from Jones and Franklin 14 although contrasts with the inverse 
frequency of these two neoplasms in other studies 17. 
 
The results of the present study must be interpreted in light of the limitations of this type of 
retrospective study. We acknowledge the limitations of not subdividing some of the locations 
of the lesions. Moreover, the selected sample may not represent the Oporto population as it is 
focused on a hospital based population. Nevertheless, this is a public and central hospital that 
receives the general population of Oporto city, including patients that were referred to a 
Stomatology centre, hence giving a large spectrum of diseases. We feel this is evidenced by 
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the 150 different diagnoses seen in this series. It is important to note that we only evaluated 
biopsied lesions, therefore oral lesions, that did not undergo any biopsy, will not be included 
in the results. Nevertheless, a strength of this study is the inclusion of the histological 
description which proves the accuracy of diagnosis compared with those studies where the 
diagnosis is only clinical. Moreover, we described the predominant location for each lesion, 
which we believe is an important contribution towards a better understanding of the various 
lesions’ epidemiology. To the best of our knowledge, this study is the first report from a large 
scale analysis of oral cavity biopsies in a central hospital, based from a population in northern 
Portugal.  
 
 
Conclusion 
 
 
The most common lesions that affected the oral cavity were non-neoplastic, with the 
fibroepithelial polyp being the most common lesion of the entire studied sample. SCC was 
the second most frequent diagnosis, which was especially common in males between the ages 
of 60-69.  This large sample therefore provides useful information about the frequency and 
distribution of oral lesions over a period of 16 years. It also allows a useful comparison to 
other countries. We believe that the data presented here will be useful in formulating 
differential diagnoses and this will be of particular interest to pathologists, oral/ maxillofacial 
surgeons and general dental practitioners. 
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Figures legends: 
Figure 1. The 10 most common histological diagnoses (1990-2006). 
 
Figure 2. The 10 most common histological diagnoses distributed by gender (1990-2006). A, 
Males; B, Females. 
 
Figure 3. The 10 most common histological diagnoses distributed by age groups (1990-
2006). A, Young patients (0 to 17 years-old); B, adult patients (18 to 64 years); and C, elderly 
patients (65+ years). 
 
Table legends: 
 
Table 1. Number of lesions in diagnostic groups distributed by gender, age and predominant 
location. 
 
Table 2. Number of non-neoplastic diagnoses by diagnostic category (including the 5 most 
prevalent lesions in each category) distributed by gender, age and predominant site. 
 
Table 3. Number of potentially malignant disorders distributed by gender, age and 
predominant site. 
 
Table 4. Number of neoplastic diagnoses by diagnostic category (including the 5 most 
prevalent in each category and tissue origin) distributed by gender, age and predominant site. 
 
Supplementary tables 
 
Table S1. Number of Inflammatory lesions/ diagnoses distributed by gender, age and 
predominant site. 
 
Table S2. Number of Infective lesions/ diagnoses distributed by gender, age and 
predominant site. 
 
Table S3. Number of Cystic lesions/ diagnoses distributed by gender, age and 
predominant site. 
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Table S4. Number of reactive lesions/ diagnoses distributed by gender, age and 
predominant site. 
 
Table S5. Number of Autoimmune or metabolic lesions/ diagnoses distributed by 
gender, age and predominant site. 
 
Table S6. Number of Congenital or development disorders/ diagnoses distributed by 
gender, age and predominant site. 
 
Table S7. Number benign neoplasms/ diagnoses distributed by gender, age and 
predominant site. 
 
Table S8. Number of malignant neoplasms/ diagnoses distributed by gender, age and 
predominant site. 
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TABLES 
 
 
Table 1. Number of lesions in diagnostic groups distributed by gender, age and predominant location. 
 n % 
Gender a  Agea  Site  
Female Male P- value b Mean ±S.D. 
P- 
value c 
Predominant 
site (%) 
P- 
value b 
a) Diagnostic Group          
Non-neoplastic 2162 63.3 1239 909 
<0.001 
45.06±18.34 
<0.001 
BM (17) 
<0.001 
OPMD 163 5.1 73 90 56.14±14.9 BM (45.4) 
Neoplasms 886 27.6 354 521 52.8±18.2 TNG (23.8) 
Total 3212 100 1666 1520 47.8±18.6 LAM (17.5) 
Legends: OPMD – Oral Potentially Malignant Disorders; LAM – Labial Mucosa; BM – Buccal Mucosa; TNG – Tongue 
a In some patients the variable is unknown 
b P-value  for the differences were  calculated using chi-square test. 
c P-value  for the differences were  calculated using Anova test. 
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Table 2. Number of non-neoplastic diagnoses by diagnostic category (including the 5 most prevalent 
lesions in each category) distributed by gender, age and predominant site. 
Diagnostic Category n % Gender
 a Agea Site 
 Female Male Mean ±S.D. Predominant (%) 
Inflammatory lesions 636 29.4 363 265 48.37±18.39 GEN (23.1%) 
   Non-specific ulcer 96 4.4 53 42 51.6±18.6 TNG (40.6) 
   Chronic sialadenitis 91 4.2 49 40 46.68±14.2 MSG (85.7) 
   Pyogenic / pregnancy granuloma 89 4.1 57 31 46.61±20.1 GEN (36) 
   Chronic inflammation  83 3.8 48 34 51.38±17.5 LAM (30.1) 
   Peripheral giant-cell granuloma 49 2.3 27 22 45.14±23.8 GEN (71.4) 
Infective lesions 45 2 31 14 47.59±19.48 MAN (20) 
   Actinomycosis 11 0.5 9 2 57±18.6 GEN (66.7) 
   Warts 9 0.4 6 3 38.89±20.6 LAM (66.7) 
   Tuberculosis 7 0.3 6 1 53.57±24 PAL (100) 
   Abscess / Fistulae 5 0.2 3 2 36.2±11.9 MNOS (40)+ MAX (40) 
   Syphilis ulcer 3 0.1 0 3 55±4.6 TNG (66.7) 
Cystic lesions 647 29.9 273 372 35.9±17.4 MAX(47.6) 
   Inflammatory odontogenic cyst 264 12.2 112 152 38.37±15.9 MAX (69.7) 
   Follicular cyst 97 4.4 40 57 32.90±17.5 MAN (50.5) 
   Mucocele/retention cyst 91 4.2 31 59 33.56±18.7 LAM (79.1) 
   Keratocyst 46 2.1 29 17 36.52±19.2 MAN (87) 
   Ameloblastoma 16 0.7 4 12 40.56±17.9 MAN (81.3) 
Reactive lesions 679 31.4 457 218 50± 16.1 BM (37.4) 
   Fibroepithelial polyp 385 17.8 268 114 48.98±16.2 BM (47) 
   Epulis fissuratum 71 3.3 61 10 55.24±11.4 GEN (52.1) 
   Fibroepithelial epulis 66 3 44 22 47.91±15.7 GEN (100) 
   Keratosis 57 2.6 27 30 52.95±14.8 TNG (47.4) 
   Epithelial hyperplasia 51 2.3 28 22 54.48±17.6 TNG (31.4) 
Auto-immune or metabolic lesions 89 4.1 72 17 49.97±15.49 LAM (62.9) 
   Sjögren’s Syndrome 48 2.2 47 1 50.83±12.8 LAM (93.8) 
   Pemphigus 13 0.6 8 5 53.54±13.6 BM (84.6) 
   Amyloidosis/amyloid substance 7 0.3 2 5 61.86±16.8 LAM (57.1) 
   Pemphigoid 4 0.2 4 0 63.5±19.8 GEN (50) 
   Erythema multiform 4 0.2 3 1 35.5±18.1 LAM (50) 
Congenital or development disorders 67 3 43 23 43.3±18.6 LAM (41.8) 
   Vascular anomalies 37 1.7 22 14 49.9±17.9 LAM (48.6) 
   Exostosis 8 0.4 6 2 46.38±15.9 MAN (62.5) 
   Melanocytic nevus 6 0.3 2 4 32.17±16.9 LAM (100) 
   Lentigo 4 0.2 4 0 30±13.3 LAM (75) 
   White spongy nevus 3 0.1 1 2 33±26.1 BM (66.7) 
Total 2162 100 1239 909 45.06±18.34 BM (17) 
Legends: LAM – Labial Mucosa; BM – Buccal Mucosa; GEN – Gingiva; TNG – Tongue; FOM – Floor Of the Mouth; PAL – 
Palate; MSG – Major Salivary Glands; MAX – Maxilla; MAN – Mandible; MNOS – Mouth NOS (non-otherwise specified). 
a In some patients the variable is unknown 
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Table 3. Number of oral potentially malignant disorders distributed by gender, age and predominant site. 
Diagnostic Category n % Gender
  Age Location 
Female Male Mean ±S.D. Predominant (%) 
   Leukoplakia * 76 46.6 28 48 57.53±15.66 BM (36.8) 
   Lichen planus 61 37.4 32 29 50.9±14.42 BM (70.5) 
   Actinic cheilitis 18 11.04 9 9 64.94±8.2 LAM (100) 
   Epithelial dysplasia** 7 4.3 3 4 62.29±10.83 BM (42.9) 
   Erythroplasia 1 0.61 1 0 70 FOM (100) 
Total 163 100 73 90 56.14±14.9 BM (45.4) 
Legends: LAM – Labial Mucosa; BM – Buccal Mucosal; FOM – Floor Of the Mouth. 
* Including cases with hyperkeratosis or epithelial hyperplasia (without dysplasia) with a clinical diagnosis of leukoplakia. 
** Including leukoplakias with dysplasia 
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Table 4. Number of neoplastic diagnoses by diagnostic category (including the 5 most prevalent in each 
category and tissue origin) distributed by gender, age and predominant site. 
Diagnostic Category n % Gender
a Agea Location 
Female Male Mean ±S.D. Predominant (%) 
Benign neoplasms  403 12.5 225 173 44.8±18.2 MSG (30.8) 
Epithelial origin       
   Pleomorphic adenoma 112 12.6 69 43 43.38±17.7 MSG (75) 
   Squamous cell papilloma 96 10.8 57 38 43.46±17.9 TNG (39.6) 
   Warthin’s tumour 25 2.8 2 23 54.50±12.8 MSG (96) 
   Basal-cell adenoma 7 0.8 5 2 56.43±11.3 MSG (71.4) 
   Adenoma NOS 6 0.7 6 0 57.3±8.8 BM+PAL (66) 
Mesenchymal origin or others       
   Haemangioma 55 6.2 34 21 49.31±17 LAM (52.7) 
   Lipoma 23 2.6 6 15 54.81±16.5 BM(26.1) 
   Fibroma 22 2.5 14 7 43.95±16.7 BM (50) 
   Lymphangioma 12 1.4 7 5 41.25±19.6 TNG (58.3) 
   Granular cell tumour 6 0.7 4 2 34.6±7 TNG (100) 
Malignant neoplasms  483 15 129 348 59.7±15.2 TNG (26.3) 
Epithelial origin       
   Squamous cell carcinoma 373 42.1 91 279 61.55±13.5 TNG (30.8) 
   Mucoepidermoid carcinoma 13 2.7 7 6 47.25±17.8 MSG (38.5) 
   Adenoid cystic carcinoma 10 1.1 3 6 53.22±13.6 FOM+MSG (60) 
   Carcinoma in situ 6 0.7 1 5 62.83±16.8 LAM (50) 
   Verrucous carcinoma 5 0.6 2 3 70.60±9.4 GEN (40) 
   Undifferentiated carcinoma 5 0.6 1 4 52±20.9 GEN (40) 
Mesenchymal origin and other´s       
   Lymphoma 25 2.8 13 12 51.12±21.7 MSG (24) 
   Kaposi’s Sarcoma 9 1 0 9 36.78±5.2 PAL (55.6) 
   Metastasis 8 0.9 2 6 67.38±12.3 LAM+TNG+MSG (75) 
   Sarcoma NOS 2 0.2 1 1 22 GEN (100) 
   Plasmocytoma 2 0.2 1 1 42.50±16.3 GEN+MAN (100) 
Total 886 100 354 521 52.8±18.2 TNG (23.8) 
Legends: NOS – Non Otherwise Specified; LAM – Labial Mucosa; BM – Buccal Mucosa; GEN – Gingiva; TNG – Tongue; FOM – Floor 
Of the Mouth; PAL – Palate; MSG – Major Salivary Glands; MAN – Mandible. 
a In some patients the variable is unknown 
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